ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $102 | +64.5% | 207 | +29.4% | 0.00% | – |
Q2 2023 | $62 | +14.8% | 160 | +10.3% | 0.00% | – |
Q1 2023 | $54 | -22.9% | 145 | -21.2% | 0.00% | -100.0% |
Q4 2022 | $70 | -99.9% | 184 | +13.6% | 0.00% | – |
Q3 2022 | $57,000 | +32.6% | 162 | +42.1% | 0.00% | – |
Q2 2022 | $43,000 | +152.9% | 114 | +107.3% | 0.00% | – |
Q1 2022 | $17,000 | +41.7% | 55 | +66.7% | 0.00% | – |
Q4 2021 | $12,000 | +500.0% | 33 | +450.0% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 6 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | – | 6 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |